Classification and characteristics of periorbital hyperpigmentation

08 January 2020


Amira M Fatin, Thavin K Mathana Sundram, Sin Sing E Tan, Marjan Sadat Seghayat, Chew Kek Lee, Navedur Rehman, Chung Keat Tan

DOWNLOAD FULL PDF VIEW RESEARCH HERE
COPY CITATION
Copied!

Abstract

Introduction

Periorbital hyperpigmentation (POH) is among the commonest esthetic and dermatological complaints. Despite its frequency, there are inadequate information detailing its incidence and prevalence. This subsequently leads to lack of comprehensive POH classification and stratification of impact on an individual's general well'being. Malaysia, a multiracial country with an expansive expatriate population, provides a unique opportunity to identify demographics of POH and subsequently attempts to group this esthetic and dermatological entity.

Objective

This study aims to develop a new and clinically relevant POH classification system and to measure impact on quality of life of POH individuals.

Methods

One hundred patients with POH were enrolled, of which all underwent clinical assessment by a clinician. Objective assessment with mexameter and digital analysis were performed. All recruited patients also completed a questionnaire based on dermatology life quality index (DLQI).

Results

Assessments noted the commonest type of POH among the subjects was vascular (51%) with the least being pigmentary (6%). The location of POH majority involved both the upper and lower eyelids (65%). DLQI scoring shows that a majority (58%) did not disrupt their quality of life.

Conclusion

Vascular type POH was the frequent most form observed, and involvement tends to occur on both eyelids. A majority of noted that POH does not affect they QOL, but the due consideration must be given in those whom are moderately and minimally affected. A thorough and comprehensive holistic approach is required in managing POH despite its focal presentation as it does affect a patient's quality of life.

Reference

  1. Freitag FM, Cestari TF. What causes dark circles under the eyes? J Cosmet Dermatol. 2007;6(3):211–215.
  2. Maruri C, Diaz L. Dark circles around the eyes. Cutis. 1969;5:979–982.
  3. Roberts WE. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment. J Drugs Dermatol. 2014;13(4):472–482.
  4. Roh MR, Chung KY. Infraorbital dark circles: definition, causes, and treatment options. Dermatol Surg. 2009;35(8):1163–1171.
  5. Alsaad SM, Mikhail M. Periocular hyperpigmentation: a review of etiology and current treatment options. J Drugs Dermatol. 2013;12(2):154–157.
  6. Hacker SM. Common disorders of pigmentation: when are more than cosmetic cover-ups required? Postgrad Med. 1996;99(6):177–186.
  7. Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22(5):443–447.
  8. Cymbalista NC, Prado de Oliveira ZN. Treatment of idiopathic cutaneous hyperchromia of the orbital region (ICHOR) with intense pulsed light. Dermatol Surg. 2006;32(6):773–783.
  9. Souza DM, Ludtke C, Souza ERM, Scandura KMP, Weber MB. Periorbital hyperchromia. Surg Cosmet Dermatol. 2011;3:233–239.
  10. Ranu H, Thng S, Goh BK, Burger A, Goh CL. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification. Dermatol Surg. 2011;37(9):1297–1303.
  11. Connelly LM. Pilot studies. Medsurg Nurs. 2008;17(6):411–412.
  12. Malakar S, Lahiri K, Banerjee U, Mondal S, Sarangi S. Periorbital melanosis is an extension of pigmentary demarcation line-F on face. Indian J Dermatol Venereol Leprol. 2007;73(5):323–325.
  13. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol. 1997;136(3):305–314.
  14. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–1440.
  15. Han SH, Byun JW, Lee WS, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol. 2012;24(3):311–318.
  16. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol. 2001;15(2):137–139.
  17. Chatterjee M, Suwal B, Malik A, Vasudevan B. A study of epidemiological, etiological, and clinicopathological factors in periocular hyperpigmentation. Pigment Int. 2018;5(1):34–42.
  18. Mashhood AA. Treatment of hyperpigmentation disorders. 2006.
  19. Amini F, Thazin Oo NM, Okechukwu PN, Seghayat MS, Ng ESC. Polymorphisms in P53 and VEGFA genes in different subtypes of periorbital hyperpigmentation in a Malaysian Chinese population. Australas J Dermatol. 2019;60(2):e99–e104.
  20. Coelho SG, Zmudzka BZ, Yin L, et al. Non-invasive diffuse reflectance measurements of cutaneous melanin content can predict human sensitivity to UVR. Exp Dermatol. 2013;22(4):266–271.

Cite

Fatin AM, Mathana Sundram TK, Tan SSE, et al. Classification and characteristics of periorbital hyperpigmentation. Skin Res Technol. 2020;26:564–570. https://doi.org/10.1111/srt.12831

COPY CITATION Copied!
DOWNLOAD FULL PDF VIEW RESEARCH HERE